Both in Biotechnology
Maze Therapeutics vs Vericel
Over the past year MAZE returned −3.0% and VCEL returned +11.9%; their daily moves had a correlation of 0.17.
MAZE −3.0% VCEL +11.9%Growth of $1, one year, split-adjusted
| Metric | MAZE | VCEL |
|---|---|---|
| Price | $32.25 | $41.09 |
| Market cap | $1.79B | $2.10B |
| Today | +6.19% | +1.43% |
| 1 month | +22.0% | 0.0% |
| 6 months | +21.4% | +11.6% |
| Year to date | −22.2% | +14.1% |
| 1 year | −2.0% | +17.2% |
| Revenue growth (YoY) | — | +22.5% |
| Gross margin | — | 72.8% |
| Net margin | — | 2.8% |
| P/E (TTM) | — | 86.9× |
| Price / sales | 89.6× | 6.9× |
| Net cash | $372.1M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 67.4% | 32.8% |
| Short % of float | 18.8% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).